Dr. David Aceituno Farias

2003 – 2009: Médico-Cirujano, Pontificia Universidad Católica de Chile.

• 2010-2013: Psiquiatra Adultos, Pontificia Universidad Católica de Chile.
• 2011: Diplomado “Psicoterapia: Fundamentos Teóricos y Práctica Clínica”.
• 2012: Diplomado “Bases Biológicas y Evolutivas de la Psiquiatría”.
• 2016-2017: Magister en Salud Mental Global, King’s College London.
• 2017-a la fecha: PhD en Health Service and Population Research (Health Economics) en King’s College London.
• 2017-2021 PhD en Health Service and Population Research (Health Economics) en King’s College London.
• 2025-a la fecha: Senior Research Fellow in Health Economics King’s College London.

Líneas de Interés:

• Intervenciones tempranas en Salud Mental.
• Psicopatología adolescencia y adultos.
• Trastornos psicóticos y de personalidad.

• 2013 – 2016: Docencia de postgrado a residentes de Psiquiatría Adultos, P. Universidad Católica de Chile.
• 2013 – 2016: Docente colaborador Internado Psiquiatría Clínica, Escuela de Medicina, P. Universidad Católica.
• 2013 – 2016: Psiquiatra Adultos Hospital de Día “Cardenal Raúl Silva Henríquez” del Complejo Asistencial Dr. Sótero del Río.
• 2013 – 2016: Psiquiatra Adultos Urgencia Psiquiátrica Clínica UC San Carlos de Apoquindo.
• 2014 – 2016: Docente Seminario “Trastornos psicóticos” residentes primer año Psiquiatría Adultos, P. Universidad Católica de Chile.
• 2021-a la fecha: Jefe Curso Neurociencias clínicas
• 2021-a la fecha: Docencia Pregrado Terapia Ocupacional y Fonoaudiología
• 2021-a la fecha: Docencia Postgrado Programa de Formación Psiquiatría Adultos.

• 2026: Aceituno D, Crossley N, Jin H, Pennington M, et al. Cost-effectiveness of early intervention in psychosis in Latin America: economic evaluation of Chilean services. BJPsych Open. 2026.
• 2026: Shore N, Morgans AK, Paracha N, Thom H, Keeney E, Orishaba P, Aceituno D, et al. Population-adjusted network meta-analyses provide new insights into the efficacy of treatment alternatives for metastatic castration-sensitive prostate cancer. J Comp Eff Res 2026; e250100.
• 2025: Shore N, Morgans AK, Paracha N, Gallagher E, Thom H, Aceituno D, et al. Efficacy and safety of treatments for metastatic castration-sensitive prostate cancer: A comprehensive network meta-analysis including final ARANOTE data. Prostate Cancer Prostatic Dis 2025; 1–9.
• 2025: Fawsitt CG, Thom H, Aceituno D, et al. External validation of the MicroSimulation Core Obesity Model (MS-COM) to predict cardiovascular outcomes, mortality and type 2 diabetes mellitus incidence and assess cost effectiveness. Pharmacoeconomics. 2025;1–13.
• 2025: Tepper A, Vásquez J, Díaz Dellarossa C, Ramirez-Mahaluf JP, Aguirre J, Barbagelata D, Aceituno D, et al. Longitudinal changes in striatocortical connectivity in first-episode psychosis associated with the emergence of treatment resistance. Schizophrenia (Heidelb) 2025; 11: 114.
• 2025: Aguirre JM, Díaz Dellarossa C, Barbagelata D, Vásquez J, Mena C, Tepper Á, Aceituno D, et al. Cognitive function at first episode in patients subsequently developing treatment-resistant schizophrenia. Schizophr Res 2025; 276: 178–84.
• 2024: Aceituno D, Fawsitt CG, Power GM, et al. Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata. J Eur Acad Dermatol Venereol. Published Online First: 24 October 2024. doi: 10.1111/jdv.20372.
• 2024: Chandrasekar A, Clark SE, Martin S, Aceituno D, et al. Making the most of big qualitative datasets: a living systematic review of analysis methods. Front Big Data. 2024;7:1455399.
• 2024: Aceituno D, Razzouk D, Jin H, Pennington M, Gadelha A, Bressan R, et al. Cost-effectiveness of early intervention in psychosis in low- and middle-income countries: economic evaluation from São Paulo, Brazil. Epidemiol Psychiatr Sci. 2024;33: e21. doi:10.1017/S2045796024000222.
• 2022: Redenz, G., Ibaceta, M. C., Aceituno, D., Balmaceda, C. & Espinoza, M. A. Health State Utility Values of Type 2 Diabetes Mellitus and Related Complications: A Systematic Review and Meta-Analysis. Value Health Reg Issues 34, 14–22 (2022).
• 2022: Crossley, N. A., Alliende, L. M., Czepielewski, L. S., Aceituno, D, et al. The enduring gap in educational attainment in schizophrenia according to the past 50 years of published research: a systematic review and meta-analysis. Lancet Psychiatry 9, 565–573 (2022).
• 2022: Alliende, L. M. Czepielewski, L. S., Aceituno, D., et al. Gender, age and geographical representation over the past 50 years of schizophrenia research. Psychiatry Res. 307, 114279 (2022).
• 2020: Aceituno D, Pennington M, Iruretagoyena B, Prina AM, McCrone P. Health State Utility Values in Schizophrenia: A Systematic Review and Meta-Analysis. Value Health. 2020. doi:10.1016/j.jval.2020.05.014.
• 2021: Pallari E, Khadjesari Z, Aceituno D, Odhiambo CA, Warner R, Bastianpillai C, et al. Implementation and Evaluation of Quality Improvement Training in Surgery: A Systematic Review. Ann Surg. 2021;274: e489–e506.
• 2021: Gao Q, Prina AM, Ma Y, Aceituno D, Mayston R. Inequalities in Older age and Primary Health Care Utilization in Low- and Middle-Income Countries: A Systematic Review. Int J Health Serv. 2021; 207314211041234.
• 2021: Jin H, Robinson S, Shang W, Achilla E, Aceituno D, Byford S. Overview and Use of Tools for Selecting Modelling Techniques in Health Economic Studies. Pharmacoeconomics. 2021;39: 757–770.
• 2020: Vera San Juan N, Aceituno D, Djellouli N, Sumray K, Regenold N, Syversen A, et al. Mental health and well-being of healthcare workers during the COVID-19 pandemic in the UK: contrasting guidelines with experiences in practice. BJPsych Open. 2020;7: e15.
• 2020: Aceituno D, Mena C, Vera N, Gonzalez‐Valderrama A, Gadelha A, Diniz E, et al. Implementation of early psychosis services in Latin America: A scoping review. Early Interv Psychiatry. 2020;48: s116.
• 2020: González-Valderrama, A; Jongsma, H; Mena, C; Castañeda, CP; Nachar, R; Undurraga, J; Crossley, N; Aceituno, D; Iruretagoyena, B; et. al. The incidence of non-affective psychotic disorders in Chile between 2005 and 2018: results from a national register of over 30 000 cases. Psychol Med. 2020; 1–10.
• 2020: Jin H, Tappenden P, Robinson S, Achilla E, Aceituno D, Byford S. Systematic review of the methods of health economic models assessing antipsychotic medication for schizophrenia. PLoS One. 2020;15: e0234996.
• 2020: Jin H, Tappenden P, Robinson S, Achilla E, MacCabe JH, Aceituno D, et al. A Systematic Review of Economic Models Across the Entire Schizophrenia Pathway. Pharmacoeconomics. 2020;38: 537–555.
• 2019: Aceituno D, Vera N, Prina AM, McCrone P. Cost-effectiveness of early intervention in psychosis: systematic review. Br J Psychiatry. 2019;215: 388–394.
• 2019: Aceituno D, Pennington M, Iruretagoyena B, Prina MA, McCrone P. Health state utility values in schizophrenia: protocol for a systematic review and meta-analysis. Evid Based Ment Health. 2019; ebmental–2019–300089.

• 2017: Ruiz MI, Aceituno D, Rada G. Art therapy for schizophrenia? Medwave. 2017;17: e6845.
• 2016: Orus C, Aceituno D. Are depot as effective as oral antipsychotics on first-episode psychosis? Medwave. 2016;16 Suppl 2: e6447.
• 2016: Jiménez-Cornejo M, Munizaga G, Aceituno D. Does adding a second antipsychotic to clozapine improve clinical response in resistant schizophrenia? Medwave. 2016;16: e6614.
• 2016: Kittsteiner Manubens L, Lobos Urbina D, Aceituno D. Is electroconvulsive therapy effective as augmentation in clozapine-resistant schizophrenia? Medwave. 2016;16: e6577.
• 2010: Jaime Santander T, Daniela Huerta F, David Aceituno F, Ximena Fuentes M. Descripción clínica y socio-demográfica de pacientes psiquiátricos internados involuntariamente bajo el régimen de hospitalización administrativa en Chile. Revista chilena de neuro-psiquiatría 49(2):157-164.